NCT02483052View on ClinicalTrials.gov

RejuvenAir Lobectomy for Safety and Histology

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Lung NeoplasmsPulmonary Neoplasms

Interventions

DEVICE

RejuvenAir

RejuvenAir

Trial Locations (1)

L6R 3J7

William Osler Health System, Brampton

Sponsors

Lead Sponsor

CSA Medical, Inc.

All Listed Sponsors

lead

CSA Medical, Inc.

INDUSTRY

NCT02483052 - RejuvenAir Lobectomy for Safety and Histology | Biotech Hunter | Biotech Hunter